Intercure Ltd. Logo

Intercure Ltd.

Produces and distributes GMP-certified, pharmaceutical-grade medical cannabis products.

INCR | TA

Overview

Corporate Details

ISIN(s):
IL0011063760
LEI:
549300KI5ESXF8F5GP06
Country:
Israel
Address:
11 USSISHKIN STREET, 3844346 HADERA

Description

Intercure Ltd. is a company focused on the production and distribution of pharmaceutical-grade medical cannabis and cannabis-based products. Operating primarily through its wholly-owned subsidiary, Canndoc Ltd., the company is a licensed producer of Good Manufacturing Practice (GMP) certified medical cannabis. Intercure's strategy involves international expansion through strategic partnerships, such as producing and distributing established brands like Cookies in European markets, and through acquisitions to access premium technologies and brands. The company leverages its EU-GMP certified manufacturing facilities to supply its products for medical use across its operational territories.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-09-01 03:36
FINANCIAL STATEMENTS As of June 30, 2023
English 36.1 KB
2023-08-15 01:50
General Meeting of Shareholders results : delist from trading on the TSX
English 120.6 KB
2023-08-15 01:50
General Meeting of Shareholders results : delist from trading on the TSX
English 36.1 KB
2023-07-25 10:40
SPECIAL MEETING OF SHAREHOLDERS will be held on 14.8.23
English 618.4 KB
2023-07-25 10:40
SPECIAL MEETING OF SHAREHOLDERS will be held on 14.8.23
English 762.3 KB
2023-07-25 10:40
SPECIAL MEETING OF SHAREHOLDERS will be held on 14.8.23
English 60.7 KB
2023-07-11 10:07
Announces Proposed Voluntary Delisting from the Toronto Stock Exchangeand shall…
English 182.1 KB
2023-07-11 10:07
Announces Proposed Voluntary Delisting from the Toronto Stock Exchangeand shall…
English 36.1 KB
2023-06-10 23:25
InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceut…
English 128.2 KB
2023-06-10 23:25
InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceut…
English 36.1 KB
2023-05-16 10:52
First Quarter 2023 Results
English 7.6 MB
2023-05-16 10:52
First Quarter 2023 Results
English 36.1 KB
2023-04-26 10:39
Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders o…
English 122.6 KB
2023-04-26 10:39
Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders o…
English 36.0 KB
2023-04-25 11:10
e Informs That An Application To Approve a Class Action Against 26 Cannabis Com…
English 127.5 KB

Automate Your Workflow. Get a real-time feed of all Intercure Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Intercure Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Intercure Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.